# Drug-drug Interaction Study of Ozanimod With Tyramine to Evaluate the Effect on Pressor Response

> **NCT03694119** · PHASE1 · COMPLETED · sponsor: **Celgene** · enrollment: 92 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** Phenelzine
- **DRUG:** Tyramine
- **DRUG:** Phenelzine placebo
- **DRUG:** ozanimod placebo
- **DRUG:** ozanimod

## Key facts

- **NCT ID:** NCT03694119
- **Lead sponsor:** Celgene
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-24
- **Primary completion:** 2019-01-08
- **Final completion:** 2019-01-08
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2019-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03694119

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03694119, "Drug-drug Interaction Study of Ozanimod With Tyramine to Evaluate the Effect on Pressor Response". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03694119. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*